Gabelli Funds LLC Grows Stake in Chemed Corporation $CHE

Gabelli Funds LLC raised its position in shares of Chemed Corporation (NYSE:CHEFree Report) by 8.5% in the third quarter, HoldingsChannel reports. The firm owned 33,601 shares of the company’s stock after acquiring an additional 2,634 shares during the period. Gabelli Funds LLC’s holdings in Chemed were worth $15,045,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Alps Advisors Inc. boosted its stake in shares of Chemed by 32.4% during the third quarter. Alps Advisors Inc. now owns 44,295 shares of the company’s stock valued at $19,833,000 after purchasing an additional 10,845 shares in the last quarter. Vest Financial LLC lifted its holdings in Chemed by 32.6% during the third quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock worth $4,344,000 after buying an additional 2,383 shares during the period. Envestnet Asset Management Inc. boosted its position in Chemed by 6.5% during the 3rd quarter. Envestnet Asset Management Inc. now owns 80,080 shares of the company’s stock valued at $35,855,000 after acquiring an additional 4,865 shares in the last quarter. Van Berkom & Associates Inc. increased its holdings in shares of Chemed by 33.0% in the 3rd quarter. Van Berkom & Associates Inc. now owns 170,813 shares of the company’s stock valued at $76,480,000 after acquiring an additional 42,390 shares during the period. Finally, Jupiter Asset Management Ltd. raised its position in shares of Chemed by 35.0% in the 2nd quarter. Jupiter Asset Management Ltd. now owns 69,563 shares of the company’s stock worth $33,872,000 after acquiring an additional 18,047 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on CHE. Royal Bank Of Canada restated a “sector perform” rating and set a $422.00 price objective (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Zacks Research lowered Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday. Jefferies Financial Group downgraded shares of Chemed from a “buy” rating to a “hold” rating in a report on Thursday, January 22nd. Weiss Ratings reissued a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Finally, Oppenheimer lowered their price target on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, February 27th. Two investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $498.00.

Read Our Latest Research Report on CHE

Chemed Trading Down 1.0%

Shares of CHE opened at $408.06 on Friday. The firm has a market cap of $5.62 billion, a PE ratio of 22.21, a P/E/G ratio of 1.62 and a beta of 0.46. Chemed Corporation has a 12 month low of $385.00 and a 12 month high of $623.60. The stock has a fifty day moving average price of $444.21 and a 200-day moving average price of $442.77.

Chemed (NYSE:CHEGet Free Report) last announced its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share for the quarter, missing the consensus estimate of $7.02 by ($0.60). Chemed had a return on equity of 25.66% and a net margin of 10.48%.The business had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. During the same quarter last year, the firm earned $6.83 earnings per share. The firm’s quarterly revenue was down .1% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. As a group, research analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Monday, February 23rd will be paid a dividend of $0.60 per share. The ex-dividend date is Monday, February 23rd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.6%. Chemed’s payout ratio is presently 13.06%.

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Featured Articles

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.